Literature DB >> 11001614

Imaging auditory verbal hallucinations during their occurrence.

M Stephane, M Folstein, E Matthew, T C Hill.   

Abstract

Entities:  

Mesh:

Year:  2000        PMID: 11001614     DOI: 10.1176/jnp.12.2.286

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


× No keyword cloud information.
  6 in total

1.  Dysconnectivity of multiple resting-state networks in patients with schizophrenia who have persistent auditory verbal hallucinations.

Authors:  Nadine Donata Wolf; Fabio Sambataro; Nenad Vasic; Karel Frasch; Markus Schmid; Carlos Schönfeldt-Lecuona; Philipp Arthur Thomann; Robert Christian Wolf
Journal:  J Psychiatry Neurosci       Date:  2011-11       Impact factor: 6.186

2.  Differential brain glucose metabolic patterns in antipsychotic-naïve first-episode schizophrenia with and without auditory verbal hallucinations.

Authors:  Guillermo Horga; Eduard Parellada; Francisco Lomeña; Emilio Fernández-Egea; Anna Mané; Mireia Font; Carles Falcón; Anna B Konova; Javier Pavia; Domènec Ros; Miguel Bernardo
Journal:  J Psychiatry Neurosci       Date:  2011-09       Impact factor: 6.186

3.  Hallucinations: Etiology and clinical implications.

Authors:  Santosh Kumar; Subhash Soren; Suprakash Chaudhury
Journal:  Ind Psychiatry J       Date:  2009-07

Review 4.  The perceptual characteristics of voice-hallucinations in deaf people: insights into the nature of subvocal thought and sensory feedback loops.

Authors:  Joanna R Atkinson
Journal:  Schizophr Bull       Date:  2006-03-01       Impact factor: 9.306

5.  Empirical evaluation of language disorder in schizophrenia.

Authors:  Massoud Stephane; Giuseppe Pellizzer; Charles R Fletcher; Kate McClannahan
Journal:  J Psychiatry Neurosci       Date:  2007-07       Impact factor: 6.186

6.  Auditory verbal hallucinations result from combinatoric associations of multiple neural events.

Authors:  Massoud Stephane
Journal:  Front Hum Neurosci       Date:  2013-05-31       Impact factor: 3.169

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.